Cargando…

DPP3: From biomarker to therapeutic target of cardiovascular diseases

Cardiovascular disease is the leading cause of death globally among non-communicable diseases, which imposes a serious socioeconomic burden on patients and the healthcare system. Therefore, finding new strategies for preventing and treating cardiovascular diseases is of great significance in reducin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Peng, Duan, Wei, Leng, Yue-Qi, Wang, Yang-Kai, Tan, Xing, Wang, Wei-Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605584/ https://www.ncbi.nlm.nih.gov/pubmed/36312232 http://dx.doi.org/10.3389/fcvm.2022.974035

Ejemplares similares

A systematic review and meta-analysis of cold exposure and cardiovascular disease outcomes
por: Fan, Jie-Fu, et al.
Publicado: (2023)

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
por: Leng, Qianru, et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Immune-related potential biomarkers and therapeutic targets in coronary artery disease
por: Liu, Chaosheng, et al.
Publicado: (2023)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets
por: Jiang, Bing, et al.
Publicado: (2023)

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
por: Hua, Cun-Cun, et al.
Publicado: (2022)

Prognostic performance of multiple biomarkers in patients with acute coronary syndrome without standard cardiovascular risk factors
por: Wang, Le, et al.
Publicado: (2022)

Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications
por: Chen, Jun, et al.
Publicado: (2021)

The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
por: Chen, Zhenzhen, et al.
Publicado: (2021)

The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders
por: Milusev, Anastasia, et al.
Publicado: (2022)

Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases
por: Luan, Yi, et al.
Publicado: (2021)

Gut immune cells—A novel therapeutical target for cardiovascular disease?
por: Ganesh, Naresh, et al.
Publicado: (2022)

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases
por: Zou, Yifei, et al.
Publicado: (2023)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

Editorial: Novelties in the Therapeutic Approaches for Chronic Heart Failure: Cardiovascular Targets and Beyond
por: Sorgente, Antonio, et al.
Publicado: (2022)

MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
por: Chen, Liuying, et al.
Publicado: (2021)

Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease
por: Montavon, Brittany, et al.
Publicado: (2022)

Editorial: Women in cardiovascular therapeutics
por: Yin, Liya, et al.
Publicado: (2023)

Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)

Pyroptosis: Role and Mechanisms in Cardiovascular Disease
por: Chen, Xinzhe, et al.
Publicado: (2022)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

SUMOylation as a Therapeutic Target for Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2021)

Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target
por: Karnati, Srikanth, et al.
Publicado: (2021)

Editorial: Novelties in the therapeutic approaches for chronic heart failure: cardiovascular targets and beyond, volume II
por: Iacoviello, Massimo, et al.
Publicado: (2023)

Acute effects of singing on cardiovascular biomarkers
por: Somayaji, Kamila, et al.
Publicado: (2022)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications
por: Xia, Xiao-dan, et al.
Publicado: (2021)

Liver biomarkers, genetic and lifestyle risk factors in relation to risk of cardiovascular disease in Chinese
por: Wang, Xinyu, et al.
Publicado: (2022)

The therapeutic potential of sphingolipids for cardiovascular diseases
por: Ya'ar Bar, Sapir, et al.
Publicado: (2023)

Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis
por: Ye, Zhen, et al.
Publicado: (2022)

Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
por: Liang, Bin, et al.
Publicado: (2020)

AMPK: Potential Therapeutic Target for Vascular Calcification
por: Lu, Yi, et al.
Publicado: (2021)

Sortilin as a Biomarker for Cardiovascular Disease Revisited
por: Møller, Peter Loof, et al.
Publicado: (2021)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Yes-Associated Protein in Atherosclerosis and Related Complications: A Potential Therapeutic Target That Requires Further Exploration
por: Sun, Congrui, et al.
Publicado: (2021)

Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future priorities
por: Yang, Ye-Wei, et al.
Publicado: (2022)

Link between sterile inflammation and cardiovascular diseases: Focus on cGAS-STING pathway in the pathogenesis and therapeutic prospect
por: Du, Yao, et al.
Publicado: (2022)

Extracellular Vesicles as Biomarkers in Cardiovascular Disease; Chances and Risks
por: Dickhout, Annemiek, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_69fa6tdm0ut1ncu0vi47rjcald